About 61% of patients with stage I or II dMMR colon cancer achieved a pathologic complete response after a single cycle of neoadjuvant pembrolizumab, new data revealed.
Taking 160 milligrams of aspirin a day cuts the risk of cancer recurrence in half among colon cancer patients with a mutation in their PI3K genes, researchers reported at the 2025 American Society of ...
Lopez saw the scan and couldn't believe his eyes. Colon cancer? He was so young, healthy, and fit. Stories like Lopez's are increasingly common. Colon cancer rates are rocketing among athletic ...